Company:  SIMULATIONS PLUS INC (SLP)
Form Type:  DEF 14A
Filing Date:  12/29/2011 
CIK:  0001023459 
Address:  42505 10TH STREET WEST
*
 
City, State, Zip:  LANCASTER, California 93534-7059 
Telephone:  661-723-7723 
Fiscal Year:  08/31 
Last Trade
Last Trade: 
$6.40  
Change: 
0.01 (0.16%)  
Trade Time: 
03:59 PM EST  
Market Cap: 
$107.78M
Description of Business
As used in this report, each of the terms �we,� �us,� �our,� the �Company� and �Simulations Plus� refers to Simulations Plus, Inc. and Cognigen Corporation, unless otherwise stated or the context otherwise requires. OVERVIEW Simulations Plus, Inc., incorporated in 1996, is a premier developer of groundbreaking drug discovery and development software for mechanistic modeling and simulation. Our software is licensed to major pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies worldwide for use in the conduct of industry-based research. We also provide consulting services to these industries. Recently, we have been exploring the application of some of our machine-learning technologies for problems in aerospace and healthcare outside of our traditional markets. Simulations Plus is headquartered in Southern California and its common stock trades on the NASDAQ Capital Market under the symbol �SLP.
Register for a Free Trial and access this filing in:     
  FORM DEF 14A
    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
    PROXY STATEMENT
    PROPOSAL No. 1: ELECTION OF DIRECTORS
      NAME AND TITLE
    PROPOSAL No. 2: RATIFICATION OF SELECTION OF INDEPENDENT ...
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
    Director Compensation
    EXECUTIVE COMPENSATION AND OTHER INFORMATION
    Compensation Committee Report
      NAME AND TITLE
      COMPENSATION TABLE
      OPTIONS
    ANNUAL REPORT
    SHAREHOLDER PROPOSALS
    OTHER MATTERS